Editor's choice

Special Feature

ESMO 2016 Immunotherapy for GU cancers: latest advances and future approaches The rapidly evolving field of immunotherapy in the treatment of genitourinary (GU) cancers was covered in a satellite symposium, sponsored by F. Hoffmann-La Roche, and held at the European Society for Medical Oncology (...

Latest Articles

FEATURED VIDEOS

Editor's choice

Axel Merseburger, Shaji Kumar, Sharlene Gill, Ahmad Awada, Paolo Ascierto and Maurice Perol discuss their experiences with the European Oncology...

Latest Videos

As well as our peer-reviewed journals, we also provide video interviews, procedures and general updates on the latest trends within the area, as well as featuring carefully selected video from our partners.
  • Mohamad Mohty talks about the emergence of novel therapies and treatments strategies and the place of stem cell transplantation in multiple myeloma.
  • Rodrigo T Calado discusses the role of telomere shortening in bone marrow failure at ASH 2017.
  • Jean-Jacques Grob discusses the role of adjuvant therapy in the treatment of melanoma at ESMO 2017. Support: The filming of this video was supported by Novartis. 1. What are the most significant...
  • Ivan Marquez Rodas discusses the unmet treatment needs in melanoma, and the benefits of adjuvant therapy in the treatment of melanoma at ESMO 2017. Support: The filming of this video was supported...
  • Dirk Schadendorf discusses the unmet need and importance, benefits and timing of adjuvant therapy in the treatment of melanoma at ESMO 2017. Support: The filming of this video was supported by...
  • Mario Mandala discusses the importance, benefits and timing of adjuvant therapy in the treatment of melanoma at ESMO 2017. Support: The filming of this video was supported by Novartis. 1. What...

ONCOLOGY INSIGHTS

touchONCOLOGY provides a selection of resources to inform physicians, clinicians and related HCPs about the latest developments in the field. The following are quick, non peer-reviewed, opinion-based updates addressing current trends and opinion on the most recent advances in the area of oncology:

Insight
First-line Treatment Options for Renal Cell Carcinoma Ulka Vaishampayan, Oncology Multidisciplinary Team Chair and Associate Professor, Karmanos Cancer Institute, Wayne State University, Detroit, MI, US
Insight
ASCO 2017 Insight – High Dose Interleukin 2 Katrina Mountfort, Touch Medical Media, Reading, UK
MONALEESA-2 secondary analyses support safety and efficacy for ribociclib/letrozole for breast cancer Catherine Amey, Senior Medical Writer, Touch Medical Media, Goring-On-Thames, UK
SIGNIFICANT increase in progression-free survival with abemaciclib plus fulvestrant in metastatic breast cancer: MONARCH 2 Catherine Amey, Senior Medical Writer, Touch Medical Media, Goring-On-Thames, UK
Pertuzumab reduced risk of invasive disease in early-stage breast cancer: APHINITY results Catherine Amey, Senior Medical Writer, Touch Medical Media, Goring-On-Thames, UK